Robert Ainscow Sells 25,000 Shares of ASP Isotopes (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 25,000 shares of the company’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $3.90, for a total value of $97,500.00. Following the transaction, the chief operating officer owned 2,256,879 shares of the company’s stock, valued at approximately $8,801,828.10. The trade was a 1.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Robert Ainscow also recently made the following trade(s):

• On Monday, June 8th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The stock was sold at an average price of $7.00, for a total value of $59,066.00.

ASP Isotopes Stock Performance

ASPI stock traded up $0.30 during mid-day trading on Friday, reaching $4.20. The company had a trading volume of 3,831,544 shares, compared to its average volume of 2,936,087. ASP Isotopes Inc. has a one year low of $3.51 and a one year high of $14.49. The stock has a market capitalization of $643.90 million, a P/E ratio of -3.18 and a beta of 3.59. The company has a quick ratio of 3.85, a current ratio of 3.87 and a debt-to-equity ratio of 0.76. The stock’s 50-day simple moving average is $4.37 and its two-hundred day simple moving average is $5.20.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.The firm had revenue of $5.12 million for the quarter, compared to the consensus estimate of $4.47 million.

Hedge Funds Weigh In On ASP Isotopes

Institutional investors have recently bought and sold shares of the stock. Quantbot Technologies LP purchased a new position in ASP Isotopes during the 3rd quarter worth approximately $34,000. BNP Paribas Financial Markets increased its position in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after purchasing an additional 2,548 shares during the last quarter. State of Wyoming acquired a new stake in ASP Isotopes in the first quarter valued at approximately $29,000. Allworth Financial LP bought a new stake in ASP Isotopes in the second quarter worth approximately $51,000. Finally, Legal & General Group Plc increased its stake in shares of ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after purchasing an additional 1,953 shares during the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on ASPI. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.